As of 2025-07-13, the Relative Valuation of Viking Therapeutics Inc (VKTX) is (24.83) USD. This relative valuation is based on P/E multiples. With the latest stock price at 31.11 USD, the upside of Viking Therapeutics Inc based on Relative Valuation is -179.8%.
The range of the Relative Valuation is (20.37) - (27.59) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 24.2x | 20.2x |
| Forward P/E multiples | 17.8x - 28.8x | 23.3x |
| Fair Price | (20.37) - (27.59) | (24.83) |
| Upside | -165.5% - -188.7% | -179.8% |
| Date | P/E |
| 2025-07-11 | -27.25 |
| 2025-07-10 | -27.40 |
| 2025-07-09 | -26.62 |
| 2025-07-08 | -26.44 |
| 2025-07-07 | -24.09 |
| 2025-07-03 | -24.69 |
| 2025-07-02 | -24.28 |
| 2025-07-01 | -23.36 |
| 2025-06-30 | -23.21 |
| 2025-06-27 | -23.23 |
| 2025-06-26 | -24.67 |
| 2025-06-25 | -23.73 |
| 2025-06-24 | -23.60 |
| 2025-06-23 | -21.77 |
| 2025-06-20 | -22.78 |
| 2025-06-18 | -23.02 |
| 2025-06-17 | -23.15 |
| 2025-06-16 | -23.61 |
| 2025-06-13 | -22.84 |
| 2025-06-12 | -25.03 |
| 2025-06-11 | -25.35 |
| 2025-06-10 | -25.52 |
| 2025-06-09 | -24.15 |
| 2025-06-06 | -24.37 |
| 2025-06-05 | -23.68 |
| 2025-06-04 | -23.65 |
| 2025-06-03 | -23.31 |
| 2025-06-02 | -22.88 |
| 2025-05-30 | -23.47 |
| 2025-05-29 | -24.66 |
| 2025-05-28 | -23.76 |
| 2025-05-27 | -23.80 |
| 2025-05-23 | -23.63 |
| 2025-05-22 | -24.29 |
| 2025-05-21 | -23.87 |
| 2025-05-20 | -25.11 |
| 2025-05-19 | -24.08 |
| 2025-05-16 | -24.90 |
| 2025-05-15 | -24.00 |
| 2025-05-14 | -23.27 |
| 2025-05-13 | -24.29 |
| 2025-05-12 | -24.79 |
| 2025-05-09 | -24.13 |
| 2025-05-08 | -24.39 |
| 2025-05-07 | -24.14 |
| 2025-05-06 | -23.66 |
| 2025-05-05 | -25.83 |
| 2025-05-02 | -25.71 |
| 2025-05-01 | -25.06 |
| 2025-04-30 | -25.28 |